248 related articles for article (PubMed ID: 20220738)
1. Antiviral drugs for influenza.
Med Lett Drugs Ther; 2009 Nov; 51(1325):89-92. PubMed ID: 20220738
[No Abstract] [Full Text] [Related]
2. Resistance to anti-influenza drugs: adamantanes and neuraminidase inhibitors.
Hurt AC; Ho HT; Barr I
Expert Rev Anti Infect Ther; 2006 Oct; 4(5):795-805. PubMed ID: 17140356
[TBL] [Abstract][Full Text] [Related]
3. Highly potent and long-acting trimeric and tetrameric inhibitors of influenza virus neuraminidase.
Watson KG; Cameron R; Fenton RJ; Gower D; Hamilton S; Jin B; Krippner GY; Luttick A; McConnell D; MacDonald SJ; Mason AM; Nguyen V; Tucker SP; Wu WY
Bioorg Med Chem Lett; 2004 Mar; 14(6):1589-92. PubMed ID: 15006410
[TBL] [Abstract][Full Text] [Related]
4. From neuraminidase inhibitors to conjugates: a step towards better anti-influenza drugs?
Cheng CK; Tsai CH; Shie JJ; Fang JM
Future Med Chem; 2014 May; 6(7):757-74. PubMed ID: 24941871
[TBL] [Abstract][Full Text] [Related]
5. Influenza--the case for combination therapy.
Krystal MR; Meanwell NA
Curr Opin Investig Drugs; 2009 Aug; 10(8):746-9. PubMed ID: 19649919
[No Abstract] [Full Text] [Related]
6. [Targeted drugs against influenza--how will this affect the epidemics?].
Pyhälä R; Ziegler T; Lumio J
Duodecim; 2000; 116(1):13-5. PubMed ID: 11764456
[No Abstract] [Full Text] [Related]
7. Current challenges in the risk assessment of neuraminidase inhibitor-resistant influenza viruses.
Gubareva LV; Fry AM
J Infect Dis; 2010 Mar; 201(5):656-8. PubMed ID: 20100087
[No Abstract] [Full Text] [Related]
8. Antiviral drugs for prophylaxis and treatment of influenza.
Med Lett Drugs Ther; 2004 Oct; 46(1194):85-7. PubMed ID: 15520621
[No Abstract] [Full Text] [Related]
9. Seasonal and pandemic influenza preparedness: science and countermeasures.
Fauci AS
J Infect Dis; 2006 Nov; 194 Suppl 2():S73-6. PubMed ID: 17163392
[TBL] [Abstract][Full Text] [Related]
10. Antiviral drugs for influenza.
Med Lett Drugs Ther; 2011 Jan; 53(1355):1-3. PubMed ID: 21212742
[No Abstract] [Full Text] [Related]
11. [Neuraminidase inhibitors against influenza].
Med Monatsschr Pharm; 1999 Sep; 22(9):262-4. PubMed ID: 10536414
[No Abstract] [Full Text] [Related]
12. [New diagnostic possibilities and medications. Fit for influenza?].
Wutzler P
MMW Fortschr Med; 2002 Nov; 144(48):18. PubMed ID: 12532540
[No Abstract] [Full Text] [Related]
13. Synthesis of influenza neuraminidase inhibitors.
Abdel-Magid AF; Maryanoff CA; Mehrman SJ
Curr Opin Drug Discov Devel; 2001 Nov; 4(6):776-91. PubMed ID: 11899618
[TBL] [Abstract][Full Text] [Related]
14. [The use of antiviral agents during an (impending) influenza pandemic].
Opstelten W; van Steenbergen JE; van Essen GA; Van der Sande MA
Ned Tijdschr Geneeskd; 2007 May; 151(18):1008-12. PubMed ID: 17508684
[TBL] [Abstract][Full Text] [Related]
15. Biotin-, fluorescein- and 'clickable' conjugates of phospha-oseltamivir as probes for the influenza virus which utilize selective binding to the neuraminidase.
Stanley M; Martin SR; Birge M; Carbain B; Streicher H
Org Biomol Chem; 2011 Aug; 9(16):5625-9. PubMed ID: 21720632
[TBL] [Abstract][Full Text] [Related]
16. [Influenza becomes treatable. Breakthrough against the last great epidemic?].
Einecke D
MMW Fortschr Med; 1999 Dec; 141(49-50):4-6. PubMed ID: 10726138
[No Abstract] [Full Text] [Related]
17. Antiviral drugs for prophylaxis and treatment of influenza.
Med Lett Drugs Ther; 2005 Nov; 47(1222):93-5. PubMed ID: 16299451
[No Abstract] [Full Text] [Related]
18. Anti-influenza drugs: the development of sialidase inhibitors.
von Itzstein M; Thomson R
Handb Exp Pharmacol; 2009; (189):111-54. PubMed ID: 19048199
[TBL] [Abstract][Full Text] [Related]
19. Neuraminidase inhibitors and their role in avian and pandemic influenza.
Crusat M; de Jong MD
Antivir Ther; 2007; 12(4 Pt B):593-602. PubMed ID: 17944267
[TBL] [Abstract][Full Text] [Related]
20. Antiviral drugs for influenza 2012-2013.
Med Lett Drugs Ther; 2012 Dec; 54(1405):97-8. PubMed ID: 23223245
[No Abstract] [Full Text] [Related]
[Next] [New Search]
